Accretive Wealth Partners LLC Has $873,000 Holdings in Danaher Co. (NYSE:DHR)

Accretive Wealth Partners LLC boosted its holdings in Danaher Co. (NYSE:DHR) by 3.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,804 shares of the conglomerate’s stock after buying an additional 127 shares during the quarter. Accretive Wealth Partners LLC’s holdings in Danaher were worth $873,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Empire Life Investments Inc. raised its position in Danaher by 23.7% in the fourth quarter. Empire Life Investments Inc. now owns 77,686 shares of the conglomerate’s stock valued at $17,833,000 after purchasing an additional 14,897 shares during the last quarter. BXM Wealth LLC bought a new position in Danaher in the fourth quarter valued at about $231,000. Spinnaker Trust raised its position in Danaher by 1.2% in the fourth quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock valued at $988,000 after purchasing an additional 50 shares during the last quarter. Center for Financial Planning Inc. raised its position in Danaher by 15.3% in the fourth quarter. Center for Financial Planning Inc. now owns 3,187 shares of the conglomerate’s stock valued at $732,000 after purchasing an additional 424 shares during the last quarter. Finally, Bank Pictet & Cie Europe AG raised its position in Danaher by 22.8% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate’s stock valued at $44,241,000 after purchasing an additional 35,730 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DHR has been the subject of several research reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 target price (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. KeyCorp increased their target price on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Stifel Nicolaus raised their price objective on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Raymond James restated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Finally, Citigroup lowered their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Danaher Trading Up 1.5 %

NYSE DHR opened at $206.66 on Friday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a one year low of $196.80 and a one year high of $281.70. The business has a 50 day simple moving average of $230.00 and a 200 day simple moving average of $249.96. The stock has a market capitalization of $149.26 billion, a P/E ratio of 39.14, a P/E/G ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the firm earned $2.09 earnings per share. Research analysts expect that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.